Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : ¿¬±¸¼Ò ´º½º
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [´ëÇѾà»çÀü³Î] ÀϺ», Ä¡¸ÅÃʱâÁýÁßÁö¿øÆÀ ³» ¾à»ç ¿ªÇÒ °­È­
³»   ¿ë

ÀϺ», Ä¡¸ÅÃʱâÁýÁßÁö¿øÆÀ ³» ¾à»ç ¿ªÇÒ °­È­

¹Ì·¡¾à±¹¼­ºñ½º »ç·Ê¿¬±¸ <2>


<Áö³­È£¿¡ À̾>
2017³â, Ä¡¸Å±¹°¡Ã¥ÀÓÁ¦
¿ì¸®³ª¶ó Á¤ºÎ´Â Ä¡¸Å È¯ÀÚÀÇ Áõ°¡¿¡ µû¸¥ °¢Á¾ »çȸÀû ºñ¿ëÀ» °æ°¨ÇϰíÀÚ, 2008³â 'Ä¡¸ÅÁ¾ÇÕ°ü¸®´ëÃ¥(2008~2012)'À» ¹ßÇ¥Çϰí, 2011³â 8¿ù 'Ä¡¸Å°ü¸®¹ý'À» Á¦Á¤Çß´Ù. 

¶ÇÇÑ 2012³â 7¿ù¿¡´Â 'Á¦2Â÷ ±¹°¡Ä¡¸Å°ü¸®Á¾ÇÕ°èȹ(2013¡­2015)'À» ¹ßÇ¥ÇØ, Ä¡¸Å°ü¸®»ç¾÷ÀǠü°èÀûÀΠ¿î¿µÀ» À§ÇÑ Á¤Ã¥Àû ±â¹ÝÀ» ¸¶·ÃÇßÀ¸¸ç, 2014³â 7¿ù¿¡´Â ³ëÀÎÀå±â¿ä¾çº¸Çè ¿ä¾çµî±Þ¿¡ 'Ä¡¸ÅƯº°µî±Þ'À» Æ÷ÇÔ½ÃÄ×´Ù. 

±×¸®°í 2015³â ¼ö¿äÀÚ Áß½ÉÀÇ 'Á¦3Â÷ ±¹°¡Ä¡¸Å°ü¸®Á¾ÇÕ°èȹ(2016¡­2020)'À» ¹ßÇ¥ÇØ °¡Á·Áö¿ø°ú Ä¡¸Å°ü·Ã ¿¬±¸ ±â¹ÝÀ» È®´ëÇϰíÀÚ Çß´Ù. 

À̿͠°°ÀÌ ¿ì¸®³ª¶ó´Â Ä¡¸Å°ü¸® Á¤Ã¥À» ²ÙÁØÈ÷ ¼ö¸³¡¤½ÃÇàÇϰí ÀÖÀ¸³ª Ä¡¸Å°ü¸®Ã¼°è´Â ¿Ï¼ºµÇÁö ¸øÇÑ Ãø¸éÀÌ ÀÖ¾ú´Âµ¥, 2017³â ±¹°¡Ä¡¸ÅÃ¥ÀÓÁ¦¸¦ ¹ßÇ¥Çϸ鼭, ÀüüÀûÀΠġ¸Å°ü¸®Ã¼°èÀǠƲÀ» ¼¼¿ì°Ô µÆ´Ù. 

Ä¡¸Å±¹°¡Ã¥ÀÓÁ¦ ¹ßÇ¥ ÀÌ Àü¿¡´Â Ä¡¸Å °ü¸®°¡ Ä¡¸Å°ü¸®¹ý°ú Ä¡¸ÅÁ¾ÇÕ°èȹ¿¡ µû¸¥ ³ëÀκ¹ÁöÀÇ ÇÑ »ç¾÷ ¿µ¿ª¿¡ ºÒ°úÇßÁö¸¸, Ä¡¸Å±¹°¡Ã¥ÀÓÁ¦¸¦ ÅëÇØ ±¹°¡ÀÇ Áö¿øÀ» È®´ëÇϰí Ä¡¸Å°ü¸®ÀÇ ÀüüÀûÀΠƲÀ» ¼¼¿ì°í, Á¤Ã¥ÀÇ À§»óÀ» °­È­Çߴٴ Àǹ̸¦ °¡Áö°Ô µÆ´Ù. 

¶ÇÇÑ, °¡Á·°ú ÁÖº¯ÀÎÀÇ °ü½É°ú µ¹º½ÀÌ ÇÊ¿äÇϴٴ Ư¼º¿¡ ÁÖ¸ñÇØ 'Áö¿ª¿¡¼­ÀÇ µ¹º½' ¶ÇÇÑ °­Á¶µÆ´Ù.
 
2017³â 9¿ù º¸°Çº¹ÁöºÎ´Â Ä¡¸Å±¹°¡Ã¥ÀÓÁ¦ ÀÏȯÀ¸·Î Àü±¹ 252°³ Ä¡¸Å¾È½É¼¾ÅÍÀÇ ¼³Ä¡¸¦ ÅëÇØ Ä¡¸ÅÁ¶±â¹ß°ß ¹× ¿¹¹æºÎÅÍ »ó´ã, »ç·Ê°ü¸®, ÀÇ·áÁö¿ø±îÁö Á¾ÇÕÀû Ä¡¸ÅÁö¿øÃ¼°è¸¦ ±¸ÃàÇϰíÀÚ Çß´Ù. 

ÇöÀç 256°³ÀÇ Ä¡¸Å¾È½É¼¾ÅͰ¡ Àü±¹¿¡ °³¼Ò°¡ µÈ »óÅÂÀÌ´Ù. Á¤Ã¥¹æÇâ¿¡ ¸ÂÃß¾î Ä¡¸ÅȯÀÚ¿¡ ´ëÇÑ »çȸÀû ´ëÀÀÀÌ ½Ã¼³ ÀÔ¼Ò¿¡¼­ ÀÌÁ¦´Â »ì´ø °÷¿¡¼­ °è¼ÓÇØ¼­ »ì¾Æ°¡´Â ÆÐ·¯´ÙÀÓÀÇ º¯È­¸¦ Áö¿ª»çȸ°¡ ÇÔ²² ÁغñÇϴ ÇüÅ·Πº¯È­Çϰí ÀÖ´Ù. 

Ä¡¸Å´Â ÀÎÁö ´É·Â ¹× ½Åü ´É·ÂÀÇ Àå¾Ö°¡ µ¿¹ÝµÇ¹Ç·Î Áö¿ªÀÇ ¸¹Àº »ç¶÷µéÀÇ °ü½É°ú µµ¿òÀÌ ÇÊ¿äÇϸç, ÀÌ·¯ÇÑ °üÁ¡¿¡¼­ Ä¡¸Å°ü¸®Ã¼°è´Â Áß¾ÓÁ¤ºÎº¸´Ù´Â Áö¿ª»çȸ°¡ Áß½ÉÀÌ µÇ´Â ÆíÀÌ º¸´Ù È¿À²ÀûÀ̶ó°í º¸°íµÅ ÀÖ´Ù. 

±× ÀÌÀ¯´Â Áö¿ª»çȸ°¡ Áß½ÉÀÌ µÅ Ä¡¸Å°ü¸® ¿ªÇÒÀ» ´Ù ÇÒ ¶§, Áö¿ª»çȸ ³»ÀÇ ÀÚ¿øÀ» º¸´Ù ½±°í Æí¸®ÇϰԠÀ̿령נ¿¬°èÇÒ ¼ö Àֱ⠶§¹®ÀÌ´Ù.  

Áö¿ª¾à±¹°ú ¾à»ç´Â ¿ì¸®³ª¶óÀÇ Àüü º¸°ÇÀÇ·á¼­ºñ½º °ø±Þü°è¿¡¼­ »ó´çÈ÷ Áß¿äÇÑ ºÎºÐÀ» Â÷ÁöÇϰí ÀÖÀ¸¸ç, º¸°ÇÀÇ·á¼­ºñ½º °ø±Þü°è¿¡¼­ ¾à»ç°¡ ´ã´çÇØ¾ß ÇÒ ¿ªÇÒÀÌ ´õ¿í È®´ëµÉ Çʿ䰡 ÀÖÀ½À» °í·ÁÇØ ¸¹Àº ³íÀǰ¡ ÀÌ·ç¾îÁö°í Àִ »óȲÀÓÀ» °í·ÁÇÒ ¶§, Ä¡¸Å¿Í °ü·ÃÇØ¼­µµ Áö¿ª»çȸ¸¦ Áß½ÉÀ¸·Î ÇÑ Áö¿ª¾à±¹ ¹× ¾à»ç°¡ ´ã´çÇØ¾ß ÇÒ ±â´É È¤Àº ¿ªÇÒ¿¡ ´ëÇÑ »çȸÀû ³íÀǰ¡ ÇÊ¿äÇÏ´Ù. 

ÀÌ¿¡ ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò´Â ¸ÕÀú À̿͠°ü·ÃÇÑ ¿Ü±¹»ç·Ê¸¦ Á¶»çÇϰí, ±¹³» Ä¡¸Å¾È½É¼¾ÅͿ͠ġ¸Å¾È½É¸¶À»À» Áß½ÉÀ¸·Î ¿î¿µµÇ´Â Ä¡¸Å¾È½É¾à±¹¿¡ ´ëÇØ »ìÆìº¸¾Ò´Ù.  

1. ±¹¿Ü ÇöȲ
(1) ÀϺ»
1) Ä¡¸Å ½ÃÃ¥ÃßÁø Á¾ÇÕÀü·«(½Å¿À·»ÁöÇ÷£) 
¡¤Ä¡¸ÅÀÇ »óÅ¿¡ µû¶ó Àû½Ã¡¤ÀûÀýÇÑ ÀǷᡤ°³È£ µîÀÇ Á¦°ø(7°³ Á¤Ã¥ Áß 2¹ø)
-ÀǷᡤ°³È£ µîÀÇ À¯±âÀûÀΠ¿¬°è¸¦ ÅëÇØ Ä¡¸Å »óÅÂÀÇ º¯È­¿¡ µû¶ó Àû½Ã¡¤ÀûÀýÇϰԠ°¡Àå ÀûÇÕÇÑ Àå¼Ò¿¡¼­ ÀǷᡤ°³È£ µîÀÌ Á¦°øµÇ´Â ¼øÈ¯ ±¸Á¶¸¦ ½ÇÇö

-Ä¡°ú Àǻ硤¾à»çÀÇ Ä¡¸Å ´ëÀÀ ´É·Â Çâ»ó ¿¬¼ö(ÀÌÀüÀÇ Á¤Ã¥ÀΠ¿À·»ÁöÇ÷£¿¡¼­´Â ÁÖÄ¡ÀǸ¸ ¾ð±ÞµÆÀ¸³ª, ½Å¿À·»ÁöÇ÷£¿¡¼­ Ä¡°úÀÇ»ç¿Í ¾à»ç Ãß°¡µÊ)

-Ä¡¸ÅÃʱâÁýÁß Áö¿øÆÀÀ¸·Î ¾à»çÀÇ ¿ªÇÒ Ã˱¸ÇÔ. 

¡¤¾à±¹Àº Ä¡¸ÅÃʱâÁýÁß Áö¿øÆÀÀ¸·Î¼­ Ä¡¸Å°¡ ÀǽɵǴ »ç¶÷À» Á¶±â¿¡ ¹ß°ßÇØ ÁÖÄ¡ÀÇ µî°ú ¿¬°èÇØ ´ëÀÀ

¡¤Ä¡¸Å È¯ÀÚÀÇ º¹¾àÁöµµ µîÀ» ÀûÀýÈ÷ ½Ç½ÃÇϴ °Í°ú Ä¡¸Å È¯ÀÚ ¹× °¡Á·¿¡ ´ëÇÑ Áö¿øÀ» ÀûÀýÇϰԠÇÒ °ÍÀÌ ¿ä±¸µÊ. 

¡¤¾à»ç Ä¡¸Å ´ëÀÀ ´É·ÂÀ» Çâ»ó½Ã۱â À§ÇÑ ¿¬¼ö±³À°À» ½ÃÇà

¡¤¾à±¹¡¤¾à»ç¸¦ È°¿ëÇÑ °Ç°­Á¤º¸ °ÅÁ¡ÀǠȰ¿ë Ãʱâ Ä¡¸ÅÀÇ °¨º° Áø´ÜÀÌ ÀÌ·ç¾îÁ® ÀûÀýÇÑ Áø·á¸¦ ¹ÞÀ» ¼ö ÀÖµµ·Ï ÇÔ. 

¡¤Ä¡¸Å È¯ÀÚÀÇ Çൿ¡¤½É¸®Áõ»ó¿¡ ´ëÀÀÇϴ µ¥´Â »ýȰ ´É·ÂÀÌ ÀúÇϵDZ⠽¬¿î ¾à¹°À̳ª º¹¿ë¿¡ ÀÇÇÑ ºÎÀۿ렵ëÀÎÀǠƯ¼ºÀ» °í·ÁÇØ ´ëÀÀÇØ¾ß ÇÔ. 

¡¤Ä¡¸Å Á¶±âÁø´ÜÀ» ÇÑ ÈÄ ´ëÀÀüÁ¦ÀÇ Á¤ºñ°¡ Áß¿äÇÔ. Á¶±âÁø´Ü ½Ã Áö¿ªÀÇ ´ç»çÀÚ ¹× Á¶Á÷ÀÇ ¿¬¶ô󸦠¼Ò°³Çϴ µî Áö¿ªÀÇ ½ÇÁ¤¿¡ µû¶ó ´ëÃ¥À» ÃßÁøÇÔ.

¡¤Ä¡¸ÅȯÀÚ¸¦ Æ÷ÇÔÇÑ °í·ÉÀڠģȭÀûÀΠÁö¿ª ¸¸µé±â ÃßÁø(7°³ Á¤Ã¥ Áß 5¹ø)

2) µµµµºÎÇö º° »ç·Ê
¡¤¾Æ¿À¸ð¸®Çö, ¾ß¸¶³ª½ÃÇö: ¾à±¹¿¡¼­ Ä¡¸Å ¼¿ÇÁüũ<Ç¥1>¸¦ ÇÒ ¼ö ÀÖµµ·Ï '°Ç°­ °£È£ ±æ°Å¸® »ó´ã ¾à±¹'À¸·Î ¿î¿µµÊ.<´ÙÀ½È£¿¡ °è¼Ó>

[±â»çÃâó] https://www.kpanews.co.kr/academy/show.asp?page=1&search_cate=8&idx=380

 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
92 [¸ÞµðÆÄ³ª´º½º]'Äڷγª19 ´ëÀÀ¡¤ÅëÇÕµ¹º½' ´Ù·é ÀǾàǰÁ¤Ã¥¿¬±¸ ¹ß°£  ±è¼±Èñ 2021-01-19 4
91 [¾à»ç°ø·Ð] ¾à±¹ °ÅÁ¡ Àڻ쿹¹æ»ç¾÷, »ý¸íÁöÅ´ÀÌ ¿ªÇÒ 'ÅåÅå'  ±è¼±Èñ 2021-01-19 2
90 [µ¥Àϸ®ÆÊ] ÀϺ»¾à±¹ÀÇ ÁøÈ­¡¦Ä«µå·Î 'Áߺ¹Åõ¾à¡¤³²Àº ¾à °ü¸®±îÁö'  ±è¼±Èñ 2021-01-19 5
89 [´ëÇѾà»çÀú³Î] ¼¼ÀÌÇÁ¾à±¹¡¤¹æ¹®¾à·á µî Ȱµ¿ Áö¼Ó Áõ°¡  ÀÌÁö¿¬ 2021-01-19 3
88 [´ëÇѾà»çÀú³Î] ¾à±¹ ó¹æÁýÁßµµ º¯È­¿Í ¾à±¹¾à»çÀÇ »çȸÀû ¿ªÇÒ Ãß±¸ ÀÌÁö¿¬ 2021-01-13 44
87 [´ëÇѾà»çÀú³Î] ÀåÁ¡Àº Ű¿ì°í ´ÜÁ¡Àº ¾ø¾Ö´Â ±³À°¹æ¹ýÀº? ÀÌÁö¿¬ 2021-01-06 77
86 [´ëÇѾà»çÀú³Î] 'Àڱ⠹ݿµ ¾ç½Ä' ÅëÇØ ¾à±¹ Àü¹®°¡ ±âÁØ ÆÄ¾Ç ÀÌÁö¿¬ 2020-12-29 80
85 [´ëÇѾà»çÀú³Î] CPD °³³ä µîÀå 80³â, ¿ì¸®³ª¶ó´Â ¾ÆÁ÷¡¦ ÀÌÁö¿¬ 2020-12-22 92
84 ¹Ì±¹¡¤¿µ±¹ ¾à»ç, ¿Â¶óÀÎÀ¸·Î ¾î¶»°Ô °øºÎÇϳª ±è¼±Èñ 2020-12-16 95
83 ÀǾàǰÁ¤Ã¥¿¬ "¿Â¶óÀÎ ¿¬¼ö±³À°¿¡ CPD µµÀÔÇØ¾ß" ±è¼±Èñ 2020-12-16 89
82 [´ëÇѾà»çÀú³Î] CPD °³³ä µîÀå 80³â, ¿ì¸®³ª¶ó´Â ¾ÆÁ÷¡¦ ÀÌÁö¿¬ 2020-12-16 77
81 [´ëÇѾà»çÀú³Î] Áö¿ª ¿©°Ç ¸ÂÃá 'Ä¡¸Å¾È½É¸¶À»'+'Ä¡¸Å¾È½É¾à±¹' ¿î¿µ ÀÌÁö¿¬ 2020-12-08 98
80 [´ëÇѾà»çÀú³Î] È£ÁÖ ¾à±¹ÀÇ Ä¡¸Å Äɾî Àü·«Àº? ÀÌÁö¿¬ 2020-12-01 109
79 [¾à»ç°ø·Ð] Ä¡¸Å±¹°¡Ã¥ÀÓÁ¦ '¿Ö ¾à»ç´Â ºüÁ³À»±î'¡¦¿Ü±¹Àº ¾î¶»°Ô? ±è¼±Èñ 2020-11-25 127
78 [µ¥Àϸ®ÆÊ] ³â µÚ Ä¡¸ÅÀα¸ 100¸¸ ½Ã´ë¡¦¾à±¹ ¿ªÇÒÀ» ã¾Æ¶ó ±è¼±Èñ 2020-11-25 129

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»